Restriction On Generic Drug Switches In DEA eRx Proposal Draws Criticism
Executive Summary
A provision in the Drug Enforcement Administration's proposed rule for electronic prescribing of controlled substances that would prohibit pharmacists from substituting generic drugs for brand name drugs is drawing fire from various stakeholders
You may also be interested in...
Generic Substitution Of Controlled Drugs Allowed In DEA e-Prescribing Rule
The Drug Enforcement Administration says generic substitution of controlled substances will be allowed at the pharmacy level when the prescription is submitted electronically
Generic Substitution Of Controlled Drugs Allowed In DEA e-Prescribing Rule
The Drug Enforcement Administration says generic substitution of controlled substances will be allowed at the pharmacy level when the prescription is submitted electronically
E-prescribing Rising: More Docs Requesting Patient Rx Benefit, History Info
Volume of electronic prescribing increased by 118 percent from 2008 to 2009.